Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System

Balsells M , Garcıa-Patterson A , Gich I , et al. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: A systematic review and metaanalysis. J Clin Endocrinol Metab, 2009; 94:4284–4291.

Battelino T , Danne T , Bergenstal RM , et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care, 2019; 42:1593–1603.

Tundidor D , Meek CL , Yamamoto J , et al. Continuous glucose monitoring time-in-range and HbA1c targets in pregnant women with type 1 diabetes. Diabetes Technol Ther. 2021 Oct;23(10):710–714.

Newman C , Ero A , Dunne FP . Glycaemic control and novel technology management strategies in pregestational diabetes mellitus. Front Endocrinol (Lausanne), 2023; 13:1109825.

Dodesini AR , Cavalli G , Ciriello E , et al. Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies. J Diabetes, 2020; 12(11):860–861.